Your browser doesn't support javascript.
loading
Dual-source powered nanomotors coupled with dual-targeting ligands for efficient capture and detection of CTCs in whole blood and in vivo tumor imaging.
Ren, Jiaoyu; Chen, Zekun; Ma, Enhui; Wang, Wenjun; Zheng, Shaohui; Wang, Hong.
Afiliación
  • Ren J; School of Chemical Engineering & Technology, China University of Mining and Technology, Xuzhou, Jiangsu 221116, PR China.
  • Chen Z; School of Chemical Engineering & Technology, China University of Mining and Technology, Xuzhou, Jiangsu 221116, PR China.
  • Ma E; School of Chemical Engineering & Technology, China University of Mining and Technology, Xuzhou, Jiangsu 221116, PR China.
  • Wang W; School of Medical Imaging, Xuzhou Medical University, Xuzhou, Jiangsu 221116, PR China.
  • Zheng S; School of Medical Imaging, Xuzhou Medical University, Xuzhou, Jiangsu 221116, PR China. Electronic address: shaohui19910@163.com.
  • Wang H; School of Chemical Engineering & Technology, China University of Mining and Technology, Xuzhou, Jiangsu 221116, PR China. Electronic address: hongwang@cumt.edu.cn.
Colloids Surf B Biointerfaces ; 231: 113568, 2023 Nov.
Article en En | MEDLINE | ID: mdl-37826963
ABSTRACT
Circulating tumor cells (CTCs) are important biomarkers in cancer diagnosis. However, the specific labeling of CTCs with high capture efficiency in whole blood remains a problem. Herein, a dual-source-driven nanomotor coupled with dual-targeting ligands (CD@NM) was designed for efficient capture, specific imaging and quantitative detection of CTCs. In both water and biological fluid, CD@NMs moved autonomously under the propulsion of a magnetic field and H2O2 solution, which improved the capture efficiency of CTCs to 97.50 ± 2.38%. More importantly, specific labeling of CTCs was achieved by fluorescence quenching and recovery of fluorescent carbon dots modified on the CD@NMs. As a result, the CD@NMs exhibited efficient CTC capture, specific CTC imaging and recognition in whole blood. CD@NMs were also successfully deployed in the specific imaging of tumor tissues in vivo. On this basis, CD@NMs are expected to provide a new platform for tumor diagnosis both in vitro and in vivo.
Asunto(s)
Palabras clave

Texto completo: 1 Bases de datos: MEDLINE Asunto principal: Peróxido de Hidrógeno / Células Neoplásicas Circulantes Límite: Humans Idioma: En Revista: Colloids Surf B Biointerfaces Asunto de la revista: QUIMICA Año: 2023 Tipo del documento: Article

Texto completo: 1 Bases de datos: MEDLINE Asunto principal: Peróxido de Hidrógeno / Células Neoplásicas Circulantes Límite: Humans Idioma: En Revista: Colloids Surf B Biointerfaces Asunto de la revista: QUIMICA Año: 2023 Tipo del documento: Article